SEARCH

SEARCH BY CITATION

References

  • 1
    Goetze JP, Friis-Hansen L, Rehfeld JF, et al. Atrial secretion of B-type natriuretic peptide. Eur Heart J. 2006;27:16481650.
  • 2
    De Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet. 2003;362(9380):316322.
  • 3
    Hystad ME, Geiran OR, Attramadal H, et al. Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure. Acta Physiol Scand. 2001;171(4):395403.
  • 4
    Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347(3):161167.
  • 5
    McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation. 2002;106(4):416422.
  • 6
    Anand IS, Fisher LD, Chiang YT, et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (ValHeFT). Circulation. 2003;107(9):12781283.
  • 7
    Rienstra M, Van Gelder IC, Van den Berg MP, et al. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP. Europace. 2006;8(7):482487.
  • 8
    Gardner RS, Ozalp F, Murday AJ, et al. N-terminal probrain natriuretic peptide: a new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J. 2003;24(19):17351743.
  • 9
    Sakurai S, Adachi H, Hasegawa A, et al. Brain natriuretic peptide facilitates severity classification of stable chronic heart failure with left ventricular dysfunction. Heart. 2003;89(6):661662.
  • 10
    Miller WL, Burnett JC Jr, Hartman KA, et al. Lower rather than higher levels of B-type natriuretic peptides (NT-proBNP and BNP) predict short-term mortality in end-stage heart failure patients treated with nesiritide. Am J Cardiol. 2005;96(6):837841.
  • 11
    Chung T, Sindone A, Foo F, et al. Influence of history of heart failure on diagnostic performance and utility of B-type natriuretic peptide testing for acute dyspnea in the emergency department. Am Heart J. 2006;152(5):949955.
  • 12
    McDonagh TA, Holmer S, Raymond I, et al. NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies. Eur J Heart Fail. 2004;6(3):269273.
  • 13
    Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139(2):137147.
  • 14
    Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461470.
  • 15
    Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18(12):14401463.
  • 16
    Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26(11):11151140.
  • 17
    Devereux RB, Casale PN, Hammond IW, et al. Echocardiographic detection of pressure-overload left ventricular hypertrophy: effect of criteria and patient population. J Clin Hypertens. 1987;3(1):6678.
  • 18
    How to diagnose diastolic heart failure. European Study Group on Diastolic Heart Failure. Eur Heart J. 1998;19(7):9901003.
  • 19
    McMurray JJ, Pfeffer MA. Heart failure. Lancet. 2005; 365(9474):18771889.
  • 20
    Wallen T, Landahl S, Hedner T, et al. Brain natriuretic peptide in an elderly population. J Intern Med. 1997;242(4):307311.
  • 21
    Hogenhuis J, Voors AA, Jaarsma T, et al. Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT-ANP and BNP/NT-proBNP. Eur J Heart Fail. 2005;7(1):8186.
  • 22
    Horl WH. Natriuretic peptides in acute and chronic kidney disease and during renal replacement therapy. J Investig Med. 2005;53(7):366370.
  • 23
    O'Donoghue M, Chen A, Baggish AL, et al. The effects of ejection fraction on N-terminal ProBNP and BNP levels in patients with acute CHF: analysis from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. J Card Fail. 2005;11(suppl 5):S9S14.
  • 24
    Maisel AS, Koon J, Krishnaswamy P, et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J. 2001;141(3):367374.
  • 25
    Dokainish H, Zoghbi WA, Lakkis NM, et al. Comparative accuracy of B-type natriuretic peptide and tissue Doppler echocardiography in the diagnosis of congestive heart failure. Am J Cardiol. 2004;93(9):11301135.
  • 26
    Dokainish H, Zoghbi WA, Lakkis NM, et al. Optimal noninvasive assessment of left ventricular filling pressures: a comparison of tissue Doppler echocardiography and B-type natriuretic peptide in patients with pulmonary artery catheters. Circulation. 2004;109(20):24322439.
  • 27
    Hogenhuis J, Jaarsma T, Voors AA, et al. Correlates of B-type natriuretic peptide and 6-min walk in heart failure patients. Int J Cardiol. 2006;108(1):6367.